Hoda E. Kafl

Saroglitazar protects against cadmium-induced hepatorenal injury in rats by suppressing NF-κB and upregulating Nrf2

Introduction Cadmium (Cd) toxicity is one of the major public health problems because of its long half-life (10–30 years). Exposure to Cd can cause toxicity that affects several organs, including the liver and the kidney. Saroglitazar is highlighted in this study as a potential preventative medication against hepatic-r...